Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer’s disease is a research paper published in Brain and Neuroscience Advances (2022). On theSindex it has a DataRank of 0.650. It has been cited 17 times, with 14 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0.216
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 14 citers.
National Institutes of Health
Grant: R56-AG072473
UK Dementia Research Institute
Grant: Spires-Jones
H2020 European Research Council
Grant: 681181
Imaging synaptic contributors to dementia
Medical Research Council
Grant: MC_EX_MR/N50192X/1
NIA NIH HHS
Grant: R56 AG072473
Medical Research Council
Grant: UKDRI-4003
National Institutes of Health
Grant: 1R56AG072473-01
Neuronal mechanisms of altered circuit excitability in early Alzheimer's
Autifony Therapeutics
FWCI
1.39
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
sj-pdf-1-bna-10.1177_23982128221086464 – Supplemental material for Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer’s disease
Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer’s disease
Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer’s disease
sj-pdf-1-bna-10.1177_23982128221086464 – Supplemental material for Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer’s disease